Carolina Research Leads to Effective Experimental Pill to Treat COVID-19
October 8, 2021
University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19, a pill developed by the pharmaceutical companies Merck and Ridgeback Biotherapeutics. William Fischer, MD, at the 黑料网 led pivotal clinical trials on the...